Seeking Alpha
  • The Scientist
    SRPT 50:50 chance of FDA approval without P3. Huge unmet medical need vs. extremely small P2 study.
    7/24/12
    Reply (1)
    • EquiMan: Upside ridiculous if you are right. 10-15 more patients would have helped.
      8/28/12